Study explores promise, limitations of 18F-FLT in cancer imaging

05/20/2013 | MolecularImaging.net

A review published in The Journal of Nuclear Medicine found that while 18F-FLT has been seen as a promising tracer for imaging cancer proliferation, its performance falls short of the standard FDG. In one study, 18F-FDG showed higher sensitivity in detecting pancreatic tumors. In another study, 18F-FLT was found to have lower uptake than FDG in head and neck cancers. "As F-18 FLT finds more applications in proliferation imaging, its benefits and limitations will be better known," researchers said.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN